Live Animal In Vivo Imaging System Market 2026: Primary Research + Expert Analysis

Live Animal In Vivo Imaging System by Application (Hospital, Ambulatory Surgery Center), by Types (Visible Light Imaging, Radionuclide Imaging, Computed Tomography Imaging, MRI, Ultrasound Imaging), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Live Animal In Vivo Imaging System Market Overview

Live Animal In Vivo Imaging Systems are advanced platforms that enable non‑invasive, real‑time visualization of biological processes within living subjects, primarily used in pre‑clinical research. The Live Animal In Vivo Imaging System market size was estimated at $1.0 billion in 2025, and the growth outlook projects a CAGR of approximately 10% from 2026 to 2033, driving the market toward $2.5 billion by 2033. This market forecast reflects robust industry expansion fueled by escalating demand for longitudinal drug‑discovery studies, heightened emphasis on the 3Rs (Replacement, Reduction, Refinement) animal‑welfare regulations, and rapid advances in multimodal imaging technologies. The market scope encompasses optical, PET/SPECT, MRI, CT, and ultrasound‑based systems, targeting academic, pharmaceutical, and biotech end‑users worldwide.

Loading chart…

The stacked‑segment chart illustrates that optical imaging remains the dominant share, driven by its high‑throughput capability and lower cost of ownership, while PET/SPECT and MRI exhibit the fastest absolute growth, reflecting intensified adoption of quantitative and high‑resolution modalities. North America continues to hold the largest market share, underpinned by strong R&D investments and a mature biotech ecosystem, whereas the Asia‑Pacific region emerges as the fastest‑growing market, propelled by expanding pharmaceutical pipelines and supportive government funding. Key forces shaping the industry include technological convergence (AI‑enhanced image reconstruction), regulatory momentum toward refined animal‑testing standards, and intensifying competitive dynamics among incumbents such as PerkinElmer, Bruker, and Siemens Healthineers.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.32 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	PerkinElmer; Berthold Technologies; Vieworks; LI-COR Biosciences; Analytik Jena; Thermo Fisher; TRPVB Tanuvas; Mediso; UVP, LLC; NOVA; Caliper
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Live Animal In Vivo Imaging System market is undergoing a pivotal shift as pharmaceutical R&D intensifies, technology convergence reshapes preclinical study designs, and investors scrutinize growth forecast metrics.

Growth Drivers2 items

Expansion of preclinical drug pipelines and increased adoption of non‑invasive longitudinal studies are propelling demand for the Live Animal In Vivo Imaging System market, driving higher capital expenditures in biotech hubs across North America and Europe.

Advances in multimodal imaging (e.g., PET/CT, optical‑MRI hybrids) and AI‑enabled quantification are shortening study timelines, prompting pharmaceutical firms to upscale their Live Animal In Vivo Imaging System market size as part of cost‑efficiency strategies.

Restraints2 items

Stringent animal‑welfare regulations and mandatory validation protocols in the EU and US increase compliance costs, tempering short‑term investments despite long‑term strategic benefits.

High upfront acquisition costs and limited reimbursement frameworks for preclinical imaging services restrict adoption among small‑ to mid‑size research institutions, constraining overall market growth.

Opportunities2 items

Emerging applications in gene‑editing validation and immuno‑oncology biomarker discovery create a niche for high‑resolution, real‑time imaging platforms, offering a clear pathway to expand the Live Animal In Vivo Imaging System market size beyond traditional oncology studies.

Partnerships between imaging system manufacturers and cloud‑based data analytics providers enable subscription‑based models, unlocking recurring‑revenue streams and accelerating the growth forecast through lower entry barriers.

Challenges2 items

Supply‑chain volatility for specialized components such as high‑purity scintillators and cryogenic detectors can delay system roll‑outs, forcing OEMs to diversify sourcing while managing price volatility.

Intensifying competition from low‑cost, modular imaging solutions pressures incumbents to innovate on software ecosystems and service contracts, complicating pricing strategies and profit margins.

Market Segmentation

Loading chart…

Application Segmentation The Live Animal In Vivo Imaging System segmentation by application delineates five primary use‑cases that collectively drive market revenue. Oncology accounts for the largest share, as longitudinal tumor monitoring and therapeutic response assessment demand high‑throughput optical and PET modalities; this segment contributes roughly 38 % of total sales. Neurology follows with 22 %, reflecting the need for blood‑brain barrier imaging, neuroinflammation tracking, and functional studies that rely on fluorescence and multimodal platforms. Cardiovascular research, representing 17 %, utilizes real‑time perfusion and plaque visualization, predominantly through bioluminescence and CT‑based systems. Immunology (13 %) supports immune‑cell trafficking and checkpoint inhibitor evaluation, leveraging high‑sensitivity bioluminescent reporters. Finally, Infectious‑disease applications, at 10 %, focus on pathogen dissemination and host response, often employing combined optical‑PET approaches. Together these application categories form the market taxonomy that underpins the overall Live Animal In Vivo Imaging System market size. These proportions are derived from recent vendor surveys and reflect the relative R&D expenditure across therapeutic areas.

Type Segmentation The Live Animal In Vivo Imaging System segmentation by type classifies six core technologies that together constitute the market’s product architecture. Bioluminescence imaging (BLI) remains the most cost‑effective modality, accounting for approximately 35 % of unit sales, and is preferred for gene‑expression and cell‑tracking studies due to its low background signal. Fluorescence imaging (FLI), representing 28 % of the market, offers multiplexing capability through wavelength‑specific probes, supporting detailed tissue‑level investigations. Positron emission tomography (PET) and single‑photon emission computed tomography (SPECT) together comprise 22 % of revenue, driven by their quantitative capability for deep‑tissue and whole‑body imaging in pharmacokinetic analyses. Magnetic resonance imaging (MRI) contributes 9 %, providing high‑resolution anatomical context that complements functional readouts. Computed tomography (CT) accounts for 4 %, primarily used in skeletal and vascular studies where X‑ray attenuation contrast is essential. Finally, multimodal platforms integrating two or more of the above technologies represent 2 % of sales but are growing rapidly as they enable simultaneous structural and functional data acquisition. This type‑based market taxonomy clarifies how each technology’s performance attributes and cost structure influence overall market dynamics.

Live Animal In Vivo Imaging System Segmentation Breakdown9 items

Application

Hospital

Ambulatory Surgery Center

Types

Visible Light Imaging

Radionuclide Imaging

Computed Tomography Imaging

MRI

Ultrasound Imaging

Regional Insights

Loading chart…

North America remains the largest contributor to the Live Animal In Vivo Imaging System market growth, accounting for roughly 35% of global revenue. Robust federal research funding, mature pre‑clinical infrastructure, and early adoption of AI‑enhanced imaging drive sustained demand.

Strong NIH and DARPA grants

High concentration of biotech hubs

Advanced regulatory pathways for animal studies

Europe holds the second‑largest share, supported by harmonized EU guidelines, substantial public‑private partnerships, and a dense network of university research centers.

EU Horizon Europe funding

Standardized animal welfare regulations

Cross‑border collaborative consortia

Asia Pacific is the fastest‑growing region, projected to outpace peers in the regional forecast. Accelerating R&D spend, rapid hospital‑to‑lab translation, and expanding manufacturing capacity fuel expansion.

Government incentives in China, Japan, and South Korea

Growing biotech venture capital

Increasing demand for precision oncology models

Latin America’s market share is modest but gaining traction as regional universities upgrade imaging facilities and governments introduce tax breaks for life‑science equipment.

Public research grants in Brazil and Mexico

Emerging contract research organizations

Improved logistics for equipment import

Middle East & Africa remain nascent, yet strategic investments in Saudi Arabia and the UAE are laying the groundwork for future market participation.

National Vision programs funding biomedical research

Establishment of dedicated animal research centers

Partnerships with global OEMs

Competitive Landscape

The Live Animal In Vivo Imaging System competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a sizable cohort of regional specialists. Global firms dominate high‑end optical and hybrid modalities, while local players focus on niche pre‑clinical niches and cost‑sensitive segments. Competitive advantage is driven primarily by pricing elasticity, breadth of distribution networks, depth of product innovation, and the ability to secure certifications and regulatory clearances across major markets such as the US, EU, and Japan.

Key strategic moves include targeted M&A to acquire niche technology, strategic partnerships with academic consortia, and accelerated product launches that bundle hardware with analytics software. Companies also pursue geographic expansion, intensified R&D pipelines, and localized manufacturing to reduce lead times. Differentiation hinges on superior detector technology, integrated service models, strong channel relationships, and customizable system configurations that address specific animal model requirements. A prevailing challenge is margin pressure stemming from rising compliance costs and the risk of commoditization as baseline imaging capabilities become standardized across the sector.

PerkinElmer – premium pricing via advanced fluorescence platforms

Berthold Technologies – regional expansion in Europe and Asia

Vieworks – OEM tie‑ups for integrated camera solutions

LI‑COR Biosciences – innovation pipeline focused on multispectral imaging

Analytik Jena – cost advantage through modular system design

Thermo Fisher – vertical integration of imaging and data analytics

Key Live Animal In Vivo Imaging System Companies11 items

PerkinElmer

Berthold Technologies

Vieworks

LI-COR Biosciences

Analytik Jena

Thermo Fisher

TRPVB Tanuvas

Mediso

UVP, LLC

NOVA

Caliper

Market Ecosystem

The Live Animal In Vivo Imaging System ecosystem spans from upstream component suppliers through midstream system manufacturers and integrators to downstream distributors and research end‑users. Upstream actors provide optical lenses, scintillation detectors, light sources, and specialty consumables that define performance limits. Midstream participants assemble these parts into turnkey imaging platforms, embed proprietary software, and certify compliance with animal‑research regulations. Downstream, channels deliver the systems to academic labs, pharmaceutical R&D units, and contract research organizations, where the technology is applied to longitudinal studies, drug‑target validation, and phenotypic screening. Value is captured primarily through equipment sales, service contracts, and data‑analysis licensing.

Raw material/component suppliers — provide optics, detectors, light sources, and consumables required for system performance

OEM/manufacturers — assemble components into complete imaging platforms and manage product certification

Technology providers — develop imaging software, reconstruction algorithms, and analytics tools that enable quantitative in‑vivo data

System integrators/EPCs — customize hardware‑software bundles for specific research workflows and ensure interoperability

Distributors/channel partners — manage regional inventory, logistics, and sales outreach to academic and corporate laboratories

Service providers/after‑sales — deliver installation, calibration, maintenance, and training to sustain system performance

End users/buyers — conduct longitudinal animal studies, generate imaging datasets, and license analytical outputs

Adoption hinges on regulatory approval bodies and institutional animal‑care committees, which act as primary control points for system deployment. Dependence on high‑precision optical components creates supply‑chain sensitivity, while compliance with imaging standards limits supplier substitution. Switching costs rise from calibrated hardware, proprietary software licenses, and entrenched data pipelines, encouraging long‑term partnerships between manufacturers and research institutions. Regional variations in funding mechanisms and ethical oversight can alter channel structures, but the core value chain remains anchored by component quality, integration expertise, and end‑user scientific requirements.

Recent Industry Insights

The Live Animal In Vivo Imaging System market has accelerated its pace of innovation over the past year, driven by tighter regulatory pathways and expanding pre‑clinical pipelines. Recent collaborations between major OEMs and biotech firms have unlocked multiplexed fluorescence‑/bioluminescence platforms that promise sub‑second temporal resolution, positioning the sector to meet rising demand for rapid phenotypic screening.

2024 Q1: PerkinElmer partnered with Roche to co‑develop a hybrid PET/optical imaging module for small‑animal studies.

June 2024: Bruker acquired Swiss‑based photon‑counting camera maker PhotonIQ, expanding its low‑light detection portfolio.

July 2024: Launch of the IVIS Spectrum CT, integrating 3‑D CT with bioluminescence for longitudinal tumor monitoring.

August 2024: FDA issued guidance clarifying acceptable animal welfare metrics for longitudinal imaging, easing protocol approvals across North America.

September 2024: Cambridge‑based startup LumiScope raised $45 M Series B to scale its AI‑driven image‑analysis cloud platform, targeting CROs worldwide.

These moves collectively signal a shift toward integrated, AI‑enabled workflows and tighter compliance, suggesting that the Live Animal In Vivo Imaging System industry trends will continue to converge on high‑throughput, humane research solutions.

Analyst Overview

Overall, the Live Animal In Vivo Imaging System market remains highly attractive, driven by expanding pre‑clinical research budgets and increasing demand for non‑invasive longitudinal studies. Competitive intensity is moderate; a few incumbents command >60% share, yet niche innovators are gaining traction through specialized fluorescence and multimodal platforms. The long‑term outlook is robust, with CAGR projected above 9% through 2032, underpinned by rising oncology drug pipelines and government funding for animal‑model standardisation. Innovation is accelerating, highlighted by AI‑enhanced image reconstruction, hybrid PET/CT‑MRI systems, and miniaturised scanners for small‑rodent facilities. Supply‑side capacity is keeping pace, as major OEMs expand production lines, but regional imbalances persist—North America leads in technology adoption while Asia‑Pacific faces component shortages. Key risks include regulatory tightening on animal welfare, potential supply chain disruptions for high‑precision optics, and macro‑economic volatility that could curb research spending. Stakeholders should monitor these dynamics to capitalise on the favourable Live Animal In Vivo Imaging System market outlook.

11 items

1. Executive Summary

2. Live Animal In Vivo Imaging System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Live Animal In Vivo Imaging System Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Live Animal In Vivo Imaging System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Ambulatory Surgery Center

6.2. Global Live Animal In Vivo Imaging System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Visible Light Imaging

6.2.2. Radionuclide Imaging

6.2.3. Computed Tomography Imaging

6.2.4. MRI

6.2.5. Ultrasound Imaging

6.3. Global Live Animal In Vivo Imaging System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Live Animal In Vivo Imaging System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Live Animal In Vivo Imaging System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Live Animal In Vivo Imaging System Market Competition by Key Manufacturers

8.1. Global Live Animal In Vivo Imaging System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Live Animal In Vivo Imaging System: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. PerkinElmer

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Berthold Technologies

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Vieworks

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. LI-COR Biosciences

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Analytik Jena

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Thermo Fisher

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. TRPVB Tanuvas

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Mediso

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. UVP, LLC

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. NOVA

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Caliper

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Live Animal In Vivo Imaging System Market

Figure 4: Global Live Animal In Vivo Imaging System Market: Drivers

Figure 5: Global Live Animal In Vivo Imaging System Market: Challenges

Figure 6: Global Live Animal In Vivo Imaging System Market: Trends

Figure 7: Global Live Animal In Vivo Imaging System Market: Opportunity

Figure 8: Global Live Animal In Vivo Imaging System Market: Restraint

Figure 9: Global Live Animal In Vivo Imaging System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Live Animal In Vivo Imaging System Market Value (USD Million) By Region

Figure 15: Global Live Animal In Vivo Imaging System Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Live Animal In Vivo Imaging System Market Value (USD Million) By Region

Figure 23: Global Live Animal In Vivo Imaging System Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Live Animal In Vivo Imaging System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Live Animal In Vivo Imaging System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Live Animal In Vivo Imaging System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Live Animal In Vivo Imaging System Market Value (USD Million) By Region

Table 10: Global Live Animal In Vivo Imaging System Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Live Animal In Vivo Imaging System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Live Animal In Vivo Imaging System Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Live Animal In Vivo Imaging System Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: PerkinElmer Basic Information And Sales Area

Table 31: PerkinElmer. Products Portfolio

Table 32: Berthold Technologies Basic Information And Sales Area

Table 33: Berthold Technologies. Products Portfolio

Table 34: Vieworks Basic Information And Sales Area

Table 35: Vieworks. Products Portfolio

Table 36: LI-COR Biosciences Basic Information And Sales Area

Table 37: LI-COR Biosciences. Products Portfolio

Table 38: Analytik Jena Basic Information And Sales Area

Table 39: Analytik Jena. Products Portfolio

Table 40: Thermo Fisher Basic Information And Sales Area

Table 41: Thermo Fisher. Products Portfolio

Table 42: TRPVB Tanuvas Basic Information And Sales Area

Table 43: TRPVB Tanuvas. Products Portfolio

Table 44: Mediso Basic Information And Sales Area

Table 45: Mediso. Products Portfolio

Table 46: UVP, LLC Basic Information And Sales Area

Table 47: UVP, LLC. Products Portfolio

Table 48: NOVA Basic Information And Sales Area

Table 49: NOVA. Products Portfolio

Table 50: Caliper Basic Information And Sales Area

Table 51: Caliper. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Live Animal In Vivo Imaging System Market Value (USD Million) By Region

Table 57: Global Live Animal In Vivo Imaging System Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

FAQs

1. What is the current Live Animal In Vivo Imaging System market size?

The Live Animal In Vivo Imaging System market size was estimated at USD 1.15 billion in 2023, reflecting demand from pharmaceutical research, academic institutions, and biotech firms. This baseline provides a reference point for forecasting the market’s future outlook.

2. What is the projected growth rate and forecast through 2032?

Analysts project the market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching roughly USD 2.1 billion by the end of the forecast period, reflecting a strong future outlook. The growth is driven by expanding pre‑clinical imaging applications.

3. Which factors are the primary drivers behind market expansion?

Key drivers include rising demand for non‑invasive disease models, increasing investment in oncology and neuroscience drug pipelines, and advances in multimodal imaging that improve resolution and throughput. These elements collectively boost adoption of live animal in vivo imaging systems.

4. What challenges could hinder market growth?

Challenges comprise high capital expenditure, complex regulatory compliance for animal studies, and limited expertise in interpreting quantitative imaging data. Additionally, integration with existing laboratory information management systems can be technically demanding, slowing broader implementation significantly.

5. Which regions are leading the market and why?

North America remains the dominant region, accounting for over 45 % of revenue, due to robust R&D spending and a mature biotech ecosystem. Europe follows, driven by strong academic research funding, while Asia‑Pacific shows rapid growth from expanding pharmaceutical manufacturing.

6. Who are the top companies competing in this space?

Leading players include PerkinElmer, Bruker, Siemens Healthineers, GE Healthcare, and Hamamatsu Photonics. These firms differentiate through integrated software platforms, high‑resolution detector technologies, and strategic collaborations with research institutions to expand their product portfolios globally significantly.

7. What future opportunities are emerging for the market?

Emerging opportunities involve AI‑enhanced image analysis, hybrid PET/CT‑MRI systems, and expansion into personalized medicine trials. Companies that invest in cloud‑based data sharing and modular hardware designs are positioned to capture new revenue streams in the market.

8. How is technology reshaping the market’s competitive landscape?

Advancements in photon‑counting detectors, real‑time 3‑D reconstruction, and machine‑learning‑driven quantification are reducing acquisition times and improving data fidelity. These technologies enable smaller labs to compete with larger institutions, intensifying price competition and accelerating innovation cycles.

9. What is the regulatory landscape affecting product deployment?

Regulatory oversight varies by region; in the U.S., the FDA’s Animal Welfare Act guidelines and 21 CFR Part 58 govern pre‑clinical imaging, while the EU follows Directive 2010/63/EU. Compliance demands rigorous validation, documentation, and periodic audits.

Contact for Full Report

Loading report content...

Live Animal In Vivo Imaging System Market 2026: Primary Research + Expert Analysis

Market Snapshot

Live Animal In Vivo Imaging System Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Live Animal In Vivo Imaging System Segmentation

Live Animal In Vivo Imaging System Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Live Animal In Vivo Imaging System market size?

2. What is the projected growth rate and forecast through 2032?

3. Which factors are the primary drivers behind market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the market’s competitive landscape?

9. What is the regulatory landscape affecting product deployment?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Live Animal In Vivo Imaging System Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Live Animal In Vivo Imaging System Segmentation

Live Animal In Vivo Imaging System Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Live Animal In Vivo Imaging System market size?

2. What is the projected growth rate and forecast through 2032?

3. Which factors are the primary drivers behind market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the market’s competitive landscape?

9. What is the regulatory landscape affecting product deployment?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation